Microtubule-Tau Interaction as a Therapeutic Target for Alzheimer's Disease

被引：11
|
作者：
Pachima, Yanina Ivashko [1 ,2 ]
Zhou, Liu-yao [3 ,4 ]
Lei, Peng [3 ,4 ,5 ]
Gozes, Illana [1 ,2 ]
机构：
[1] Tel Aviv Univ, Lily & Avraham Gildor Chair Invest Growth Factors, Dept Human Mol Genet & Biochem,Adams Super Ctr Br, Elton Lab Neuroendocrinol,Sackler Fac Med, IL-69978 Tel Aviv, Israel
[2] Tel Aviv Univ, Sagol Sch Neurosci, IL-69978 Tel Aviv, Israel
[3] Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Dept Neurol, Chengdu 610041, Sichuan, Peoples R China
[4] Collaborat Innovat Ctr Biotherapy, Chengdu 610041, Sichuan, Peoples R China
[5] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Oxidat Biol Unit, Parkville, Vic 3052, Australia
来源：
JOURNAL OF MOLECULAR NEUROSCIENCE | 2016年 / 58卷 / 02期
基金：
中国国家自然科学基金; 以色列科学基金会;
关键词：
DEPENDENT NEUROPROTECTIVE PROTEIN; AMYLOID-BETA-PROTEIN; PAIRED HELICAL FILAMENT; SIGNAL-REGULATED KINASE; FAST AXONAL-TRANSPORT; NAP DAVUNETIDE; MOUSE MODEL; NEURONAL DIFFERENTIATION; ENDOGENOUS TAU; DRUG CANDIDATE;
D O I：
10.1007/s12031-016-0715-x
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：145 / 152
页数：8
相关论文
共 50 条
  • [21] Tau modifiers as therapeutic targets for Alzheimer's disease
    Liu, Q
    Lee, HG
    Honda, K
    Siedlak, SL
    Harris, PLR
    Cash, AD
    Zhu, XW
    Avila, JI
    Nunomura, A
    Takeda, A
    Smith, MA
    Perry, G
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2005, 1739 (2-3): : 211 - 215
  • [22] Phosphorylation, microtubule binding and aggregation of tau protein in Alzheimer's disease
    Avila, J
    Lucas, JJ
    Lim, F
    Pérez, M
    Hernández, F
    Arrasate, M
    Portela, RA
    Champion, E
    Perry, G
    Smith, MA
    Nido, JD
    ALZHEIMER'S DISEASE: ADVANCES IN ETIOLOGY, PATHOGENESIS AND THERAPEUTICS, 2001, : 601 - 607
  • [23] Tau protein aggregation in Alzheimer's disease: An attractive target for the development of novel therapeutic agents
    Jouanne, Marie
    Rault, Sylvain
    Voisin-Chiret, Anne-Sophie
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2017, 139 : 153 - 167
  • [24] Interaction between Aβ and Tau in the Pathogenesis of Alzheimer's Disease
    Zhang, Huiqin
    Wei, Wei
    Zhao, Ming
    Ma, Lina
    Jiang, Xuefan
    Pei, Hui
    Cao, Yu
    Li, Hao
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2021, 17 (09): : 2181 - 2192
  • [25] Hypometabolism as a therapeutic target in Alzheimer's disease
    Lauren C Costantini
    Linda J Barr
    Janet L Vogel
    Samuel T Henderson
    BMC Neuroscience, 9
  • [26] Mitochondria as a therapeutic target in Alzheimer's disease
    Wang, Jian
    Chen, Guo-Jun
    GENES & DISEASES, 2016, 3 (03) : 220 - 227
  • [27] γ-Secretase as a Therapeutic Target in Alzheimer's Disease
    Guardia-Laguarta, C.
    Pera, M.
    Lleo, A.
    CURRENT DRUG TARGETS, 2010, 11 (04) : 506 - 517
  • [28] NEUROGENESIS AS A THERAPEUTIC TARGET FOR ALZHEIMER'S DISEASE
    Fernandez-Verdecia, C. I.
    Diaz del Guante, M. A.
    Castillo-Diaz, L.
    Alvarez-Blanco, J.
    REVISTA DE NEUROLOGIA, 2009, 49 (04) : 193 - 201
  • [29] Gelsolin as therapeutic target in Alzheimer's disease
    Carro, Eva
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2010, 14 (06) : 585 - 592
  • [30] Hypometabolism as a therapeutic target in Alzheimer's disease
    Costantini, Lauren C.
    Barr, Linda J.
    Vogel, Janet L.
    Henderson, Samuel T.
    BMC NEUROSCIENCE, 2008, 9 (Suppl 2)
12345